Results

eNauka >  Rezultati >  Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study
Naziv: Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study
Autori D'Haens, Geert R; ...; Tarabar, Dino K; ...; (broj, koautora 17)
Godina: 2021
Publikacija: INFLAMMATORY BOWEL DISEASES
ISSN: 1078-0998 Inflammatory Bowel Diseases Pretraži identifikator
Tip rezultata: Naučni članak
Kolacija: vol. 28 br. 7 str. 1034-1044
DOI: 10.1093/ibd/izab215
WoS-ID: 000756645800001
Scopus-ID: 2-s2.0-85133855363
PMID: 34427633
PMCID: PMC9247846
URI: https://enauka.gov.rs/handle/123456789/825282
Projekat: Pfizer
Shire
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

14
SCOPUSTM
12
PubMed CentralTM
14
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.